Yang Dennis, Hasan Muhammad K, Xiao Yasi, Gabr Moamen, Jawaid Salmaan, Khalaf Mai A, Sharma Neil S, Rojas De Leon Maria Jose, Othman Mohamed O, Draganov Peter V
Center for Interventional Endoscopy, AdventHealth, Orlando, Florida, USA.
Center for Interventional Endoscopy, AdventHealth, Orlando, Florida, USA.
Gastrointest Endosc. 2024 Aug;100(2):213-220. doi: 10.1016/j.gie.2024.03.012. Epub 2024 Mar 10.
Postoperative stricture is a serious common adverse event after extensive endoscopic submucosal dissection (ESD) in the esophagus. Self-assembling peptide (SAP) gel has been shown to promote tissue healing and re-epithelialization. The aim of this study was to evaluate the effect of the SAP gel for esophageal stricture prevention after ESD.
This was a multicenter prospective study of patients who underwent esophageal ESD followed by SAP gel application between March 2022 and December 2023. Patients were included if the ESD mucosal defect involved ≥50% of the circumference of the esophagus. High-risk cases were defined as mucosal defects ≥75% of the circumference. Stricture was defined as the inability to pass an endoscope ≥8.9 mm in diameter or a narrow-caliber lumen in a patient with symptoms.
A total of 43 patients (median age, 71 years; 81.4% male) underwent ESD (median resected specimen size, 50 mm) during the study period. SAP gel (median, 3 mL) was successfully applied in all cases (median time, 4 minutes). In aggregate, stricture occurred in 20.9% (9 of 43) of the cases. Stricture developed in 30.8% of the high-risk cases: 80% (4 of 5) after circumferential ESD and 19% (4 of 21) in those with defects ≥75% but <100% of the circumference. All cases of stricture resolved with endoscopic treatment. Three cases (6.9%) of postoperative bleeding occurred and were adequately managed endoscopically.
We show that SAP gel application was easy, quick, and associated with a relatively low stricture rate comparable to other prophylactic methods. Additional comparative studies are needed to corroborate these preliminary findings.
术后狭窄是食管广泛内镜黏膜下剥离术(ESD)后一种严重且常见的不良事件。自组装肽(SAP)凝胶已被证明可促进组织愈合和再上皮化。本研究的目的是评估SAP凝胶在预防ESD后食管狭窄方面的效果。
这是一项多中心前瞻性研究,研究对象为2022年3月至2023年12月期间接受食管ESD并应用SAP凝胶的患者。如果ESD黏膜缺损累及食管周长≥50%,则纳入患者。高危病例定义为黏膜缺损≥食管周长的75%。狭窄定义为直径≥8.9 mm的内镜无法通过,或患者出现症状且管腔口径狭窄。
在研究期间,共有43例患者(中位年龄71岁;81.4%为男性)接受了ESD(中位切除标本大小为50 mm)。所有病例均成功应用了SAP凝胶(中位剂量3 mL,中位时间4分钟)。总体而言,20.9%(43例中的9例)的病例发生了狭窄。高危病例中30.8%发生了狭窄:环周ESD后80%(5例中的4例)发生狭窄,缺损≥食管周长75%但<100%的病例中19%(21例中的4例)发生狭窄。所有狭窄病例均通过内镜治疗得到缓解。发生了3例(6.9%)术后出血,并通过内镜进行了妥善处理。
我们表明,应用SAP凝胶操作简便、迅速,且狭窄率相对较低,与其他预防方法相当。需要进一步的对照研究来证实这些初步发现。